All Issue

2020 Vol.1, Issue 2 Preview Page

Review article


March 2020. pp. 10-14
Abstract

Sorry, not available.
Click the PDF button.
References
1 

Siegel RL et al., Cancer statistics, 2019. CA: a cancer journal for clinicians, 2019

10.3322/caac.2155130620402
2 

Davis R et al., Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline, The Journal of urology, 2012

10.1016/j.juro.2012.09.07823098784
3 

Lotan Y et al., Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses, Urology, 2003

10.1016/S0090-4295(02)02136-2
4 

Mowatt G et al., Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer, Health Technol Assess, 2010

10.3310/hta14040
5 

Chou R et al., Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis, Ann Intern Med, 2015

10.7326/M15-099726501851
6 

Barkan GA et al., The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology, Acta Cytol, 2016

10.1159/00044627027318895
7 

Prather J et al., Evidence-based adequacy criteria for urinary bladder barbotage cytology, J Am Soc Cytopathol, 2015

10.1016/j.jasc.2014.09.20631051710
8 

VandenBussche CJ et al., Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma, Cancer Cytopathol, 2016

10.1002/cncy.2163426524350
9 

Wojcik EM, What should not be reported as atypia in urine cytology, J Am Soc Cytopathol, 2015

10.1016/j.jasc.2014.08.00131051671
10 

Xylinas E et al., Urine markers for detection and surveillance of bladder cancer, Urologic oncology, 2014

10.1016/j.urolonc.2013.06.00124054865
11 

Oeyen E et al., Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles, Int J Mol Sci, 2019

10.3390/ijms2004082130769831PMC6412916
12 

Yafi FA et al., Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urologic oncology, 2015

13 

Konety BR, Molecular markers in bladder cancer: a critical appraisal, Urologic oncology, 2006

10.1016/j.urolonc.2005.11.02316818187
14 

Miyake M et al., Urinary BTA: indicator of bladder cancer or of hematuria, World J Urol, 2012

10.1007/s00345-012-0935-922932760PMC3537326
15 

Guo A et al., Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis, Can Urol Assoc J, 2014

10.5489/cuaj.166824940462PMC4039599
16 

Greene KL et al., Diagnostic Utility of the ImmunoCyt/ uCyt+ Test in Bladder Cancer, Rev Urol, 2006

17 

He H et al., ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis, Oncol Lett, 2016

10.3892/ol.2016.455627347104PMC4906922
18 

Darwiche F et al., Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise, Indian J Urol, 2015

19 

Phillips JL et al., Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice, BJU Int, 2006

10.1111/j.1464-410X.2006.06189.x16831139
20 

Hajdinjak T, UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing, Urologic oncology, 2008

10.1016/j.urolonc.2007.06.00218367109
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 1
  • No :2
  • Pages :10-14